ENTITY
Torrent Pharmaceuticals

Torrent Pharmaceuticals (TRP IN)

116
Analysis
Health CareIndia
Torrent Pharmaceuticals Ltd. manufactures bulk drugs and pharmaceutical formulations. The Company's formulations include cardio-vascular, psychotropic and anti-biotic drugs while its bulk drugs include atenolol, ciprofloxacin and norfloxacin. Torrent Pharmaceuticals has wholly owned subsidiaries in several regulated and less regulated international markets.
more
27 Nov 2018 05:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
341 Views
Share
17 Nov 2018 13:46

Eris Lifesciences - 2QFY19 – Acquisitions Drive Top Line Much Higher, Bottom Line to Follow by FY20E

Eris Lifesciences (ERIS IN) reported lower than expected performance in 2QFY19.  Revenues were 5% lower than our estimates at Rs 2,642 mn. The...

Logo
412 Views
Share
12 Oct 2018 09:26

Glenmark Pharmaceuticals: Attempt Out of Generic

We initiate our coverage on Glenmark Pharmaceuticals (GNP IN) (“Glenmark”)’s GNPIN 4.5% 8/21s (BB-/BB by S&P and Fitch, respectively) with a...

Logo
431 Views
Share
22 Dec 2017 12:34

Reliance Infra Sells Mumbai Electricity Business at a Good Price, But Upside Already in Price Now

Reliance Infrastructure Ltd (RELI IN) finds a buyer for its Mumbai businessReliance Infrastructure Ltd (RELI IN) yesterday announced signing of...

Logo
212 Views
Share
03 Oct 2017 10:33

Multiple Buyers for Reliance Infra's Mumbai Electricity Business - Attractiveness of Low Risk Assets

Reliance Infrastructure is selling its Mumbai Electricity Business to Greenko?As per news reports, Greenko (in a consortium with GIC of Singapore...

Logo
199 Views
Share
x